Trial intelligence / Profile preview

Curcumin for chemoradiotherapy-induced enteritis in colorectal cancer

IRCT20220429054699N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in radiation enteritis, enteritis, rectal cancer and 1 more comparing Curcumin with Placebo (2 arms). Started Apr 2017; status: completed.

02

Drugs

curcumin
03

Conditions

radiation enteritisenteritisrectal cancercolorectal cancer (CRC)

Beyond the preview

Go deeper on IRCT20220429054699N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220429054699N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call